News in brief

27 Mar 1998

* Lehman Brothers has completed one of the most successful French IPOs this year with the sale of stock in bio-tech group Transgene. The offering, which was around 15 times oversubscribed, results in a dual listing for the company on the Nouveau Marché and Nasdaq. Lehman and ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial